Ethyl pyruvate alleviates NLRP3/Caspase‐1/GSDMD‐mediated neuronal pyroptosis in neonatal rats with hypoxic–ischemic brain damage
International Journal of Developmental Neuroscience · 2024
DOI: 10.1002/jdn.10357 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2024. Verfasst von Sha Sha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Caspase 1, Hypoxia-Ischemia, Brain, Neurons, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Guangzhou People's Livelihood Science and Technology Project, Natural Science Foundation of Guangdong Province, Kashgar Guangjian Group Co., Ltd.
Abstract (Originalsprache)
Pyroptosis is an inflammation‐associated programmed cell death, and neuroinflammation is strongly associated with severe neurological deficits in neonatal hypoxic–ischemic encephalopathy (HIE). Ethyl pyruvate (EP), a known anti‐inflammatory agent, has shown promise in the treatment of hypoxic–ischemic brain damage (HIBD) rats; nevertheless, the therapeutic mechanism of EP and its capacity to suppress neuronal pyroptosis in HIBD rats remain unclear. In both the neonatal Rice‐Vannucci rat model and the OGD/R model, this study examined alterations in the NLRP3/Caspase‐1/GSDMD classical pyroptosis pathway in hippocampal neurons during HIE and the potential inhibitory impact of ethyl pyruvate on this pathway. We used HE staining, immunofluorescence double staining, transmission electron microscopy, and western blot to demonstrate that EP effectively inhibited hippocampal neuronal pyroptosis and attenuated the activation of the NLRP3/Caspase‐1/GSDMD signaling pathway in HIBD rats, which resulted in a reduction of neuroinflammation and facilitated neural recovery. The results suggest that EP may be a promising neuroprotective agent for treating HIE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
ORCID-Profile: Sha Sha
Förderung
- Guangzhou People's Livelihood Science and Technology Project
- Natural Science Foundation of Guangdong Province
- Kashgar Guangjian Group Co., Ltd
Zitieren
APA
Sha, S., Jin, N., Xie, X., Zhou, R., Ruan, Y., & Ouyang, Y. (2024). Ethyl pyruvate alleviates NLRP3/Caspase‐1/GSDMD‐mediated neuronal pyroptosis in neonatal rats with hypoxic–ischemic brain damage. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.10357
Vancouver
Sha S, Jin N, Xie X, Zhou R, Ruan Y, Ouyang Y. Ethyl pyruvate alleviates NLRP3/Caspase‐1/GSDMD‐mediated neuronal pyroptosis in neonatal rats with hypoxic–ischemic brain damage. International Journal of Developmental Neuroscience. 2024. doi:10.1002/jdn.10357
BibTeX
@article{Sha2024,
author = {Sha, Sha and Jin, Ni and Xie, Xinyi and Zhou, Ruiyu and Ruan, Yanghao and Ouyang, Ying},
title = {Ethyl pyruvate alleviates NLRP3/Caspase‐1/GSDMD‐mediated neuronal pyroptosis in neonatal rats with hypoxic–ischemic brain damage},
journal = {International Journal of Developmental Neuroscience},
year = {2024},
doi = {10.1002/jdn.10357}
}
EUVIMED